Impact of a Medication Therapy Management Clinic on Glycosylated Hemoglobin, Blood Pressure, and Resource Utilization

• Published in: The Annals of pharmacotherapy Vol. 53; no. 1; p. 13
• Main Authors: Tilton, Jessica J, Edakkunnathu, Mansi G, Moran, Kellyn M, Markel Vaysman, Anna, DaPisa, Jessica L, Goen, Brianna M, Touchette, Daniel R
• Format: Journal Article
• Language: English
• Published: United States 01.01.2019
• Subjects: Aged; Blood Pressure - drug effects; Cohort Studies; Disease Management; Female; Glycated Hemoglobin A - analysis; Glycated Hemoglobin A - drug effects; Humans; Male; Medication Therapy Management - standards; Retrospective Studies; blood pressure; medication therapy management; diabetes mellitus; hospitalization; pharmacists; hypertension
• ISSN: 1542-6270
• DOI: 10.1177/1060028018794860

Medication therapy management is widely promoted to improve care. However, few well-controlled studies have evaluated its impact. We evaluated whether enrollment in a comprehensive medication therapy management clinic (MTMC) was associated with improved 12-month outcomes. This institutional review board approved study was a retrospective controlled cohort study in an academic health center serving low-income, African American and Latino populations. Between 2001 and 2011 MTMC patients were matched to control patients by age, gender, and comorbidities. Outcomes were mean change in glycosylated hemoglobin (A1C), diastolic (DBP) and systolic blood pressure (SBP), and emergency department (ED) and hospital admissions at 6 and 12 months. A difference-in-difference analysis was conducted for each outcome of interest, adjusting for observed, unmatched confounders. Patients with diabetes and receiving MTMC had greater A1C improvements, compared with controls, of 0.54% (P = 0.0067) at 6 months and 0.63% (P = 0.0160) at 12 months. At 6 months, SBP and DBP decreased in MTMC patients by 6.5 mm Hg (P = 0.0108) and 3.8 mm Hg (P = 0.0136) more than controls, respectively. At 12 months, those receiving MTMC services had SBP and DBP decreases, respectively, of 8.2 mm Hg (P = 0.0018) and 1.7 mm Hg (P = 0.2691) compared with controls. ED and hospital visits were not statistically significantly different between groups. Conclusion and Relevance: This MTMC potentially improved outcomes for referred patients in whom target goals were difficult to achieve and can serve as a model for other similar medication management programs.